Latest Regulatory Impact News

Sprintex Limited has secured its largest-ever €15.6 million purchase order with Mest Water, marking a pivotal shift from technology validation to commercial deployment. Supported by favourable European regulations and expanding markets in India, the company is poised for sustained revenue growth.

DroneShield Limited has reported a stellar 277% revenue surge in FY2025, underpinned by a booming SaaS segment and a robust $2.09 billion sales pipeline. The company is scaling manufacturing and capitalising on new US legislation to expand its counter-drone technology footprint.

Australian Dairy Nutritionals reported a 152% surge in nutritional powder sales despite regulatory hurdles in Vietnam, while expanding its Future brand footprint across China.

Nickel Industries faced a challenging December quarter due to delayed regulatory approvals impacting ore sales, yet the company kicked off 2026 with robust nickel ore sales and record earnings from its HPAL project.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

Lifestyle Communities Limited reported a challenging FY25 marked by a significant $135.5 million after-tax write-down following a VCAT ruling, while signaling early signs of recovery and strategic reset for FY26.

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

REA Group reported a solid start to FY26 with 4% revenue growth and a key acquisition that enhances its AI-driven property technology portfolio. Despite challenges in India, the Australian market’s strong yield growth and product adoption underpin a confident outlook.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.

Auking Mining’s planned acquisition of Orion Resources has hit a regulatory roadblock, while Orion’s purchase of the Cloncurry Gold Project assets faces settlement delays due to vendor conditions.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.

Platformo Ltd’s Biztrak software business experienced a 30% revenue decline in Q3 2025 due to deferred demand following changes to Malaysia’s e-invoicing compliance timeline. Despite this, the company maintained strong cash reserves and advanced key product enhancements.